Friday, July 10, 2026

Drug profile · INN

clostridium botulinum type a toxin-haemagglutinin complex

clostridium botulinum type a toxin-haemagglutinin complex (DYSPORT) is an FDA-listed pharmaceutical active ingredient. Associated with Ipsen.

TGA: approved
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — clostridium botulinum type a toxin-haemagglutinin complex

Quick answer

clostridium botulinum type a toxin-haemagglutinin complex (DYSPORT) is an FDA-listed pharmaceutical active ingredient. Associated with Ipsen.

Key facts

INN clostridium botulinum type a toxin-haemagglutinin complex
Brand DYSPORT
Originator Ipsen

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. CLIN-52120-463 Phase 3 · Ipsen · Chronic migraine
  2. CLIN-52120-464 Phase 3 · Ipsen · Episodic Migraine
  3. ITDCVC98 Phase 3 · United Therapeutics Europe · Malaria
  4. D-FR-10200-001 Phase 2 · Ipsen · Upper limb spasticity after stroke or traumatic brain injury
  5. D-FR-10200-002 Phase 2 · Ipsen · Treatment of Moderate to Severe Upper Facial Lines
  6. 115083 Approved · Disc Medicine · Dystonic tremor syndrome
  7. CLIN-52120-452 Approved · Ipsen · Upper limb spasticity (ULS) of any aetiology (in US and Fran

Frequently asked questions

What is clostridium botulinum type a toxin-haemagglutinin complex?

clostridium botulinum type a toxin-haemagglutinin complex (DYSPORT) is an FDA-listed pharmaceutical active ingredient. Associated with Ipsen.

What is the brand name for clostridium botulinum type a toxin-haemagglutinin complex?

DYSPORT is a marketed brand name for clostridium botulinum type a toxin-haemagglutinin complex. Check FDA Drugs@FDA for the current US label holder and prescribing information.